Daclatasvir: A Review in Chronic Hepatitis C. - Wikidata - wikimedia - TriplyDB

Daclatasvir: A Review in Chronic Hepatitis C.

Daclatasvir: A Review in Chronic Hepatitis C.

http://www.wikidata.org/entity/Q30392100

about

Daclatasvir combined with peginterferon-α and ribavirin for the treatment of chronic hepatitis C: a meta-analysis Chemical genetics-based development of small molecules targeting hepatitis C virus.

P2860

Q28073108-D528D2C3-1B44-4A7F-8157-53975838B5EC Q40063790-6B872BDB-5D0B-458D-BCCF-80BE3B7DB300

P2860

Daclatasvir: A Review in Chronic Hepatitis C.

http://www.wikidata.org/entity/Q30392100

description

2016 nî lūn-bûn

@nan

2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Daclatasvir: A Review in Chronic Hepatitis C.

@ast

Daclatasvir: A Review in Chronic Hepatitis C.

@en

type

label

Daclatasvir: A Review in Chronic Hepatitis C.

@ast

Daclatasvir: A Review in Chronic Hepatitis C.

@en

prefLabel

Daclatasvir: A Review in Chronic Hepatitis C.

@ast

Daclatasvir: A Review in Chronic Hepatitis C.

@en

P1433

Q30392100-F6FA0B87-8DAC-4F61-8C4E-F6AED7CBFAB3

P1476

Q30392100-CFB095FD-24F9-4E0B-B71C-6AEBDB0A2DED

P2860

Q30392100-04F10B7A-0B56-4EDF-A9F1-E85855E79FFF

Q30392100-082A6A9F-EBE5-4CA6-A3D3-2F283E21BA9A

Q30392100-17FA560A-D8EF-4F54-91B2-6E56EB52CBC5

Q30392100-1F30EE95-9929-4DAE-870D-AAA3848283FA

Q30392100-68D58313-AD91-4E67-A4FE-5EEBD2F27126

Q30392100-72CFEB02-825B-4549-B142-7C28945A5110

Q30392100-7EEFA0A4-1F21-4C68-A58A-239B5FA05552

Q30392100-85116D23-6132-43D6-9EB7-C111D05421C4

Q30392100-BEF9F98F-450D-4AD9-A46C-1AC6714FDFC5

Q30392100-BFC14C75-977D-4BE6-AD99-05898F923DA0

P2888

Q30392100-219356BE-7005-43E2-8E44-1AC3DCB11214

P304

Q30392100-24542267-EA20-4239-8941-39877A27CCF7

P31

Q30392100-F4D8DC3A-43CF-4132-B975-E06BCAFC7529

P356

Q30392100-68B28E47-6D84-407D-A448-9EF8ACA39419

P433

Q30392100-97A54765-F9A2-491D-ABCB-0DEC16A81F74

P478

Q30392100-2F5D97DD-F14C-459D-8DB1-231581E79777

P50

Q30392100-73E14D92-C2D7-44EB-8DAB-EFD70124FFE7

P577

Q30392100-2AC5C6B6-D43D-401D-BA9F-8439C8AF7239

P6179

Q30392100-CFE443DB-666E-4681-AB66-A8ADF1356D09

P698

Q30392100-0CF41470-01E9-4BDA-8303-F38E2AA00EE8

P356

S40265-016-0632-X

P1433

P1476

Daclatasvir: A Review in Chronic Hepatitis C.

@en

P2860

Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect.

Resistance analysis of the hepatitis C virus NS5A inhibitor BMS-790052 in an in vitro replicon system.

Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life

All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study.

12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral Regimens.

Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+).

Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence

Sofosbuvir: a review of its use in patients with chronic hepatitis C.

Daclatasvir: A NS5A Replication Complex Inhibitor for Hepatitis C Infection.

P2888

s40265-016-0632-x

P304

1381-1391

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-016-0632-X

http://www.w3.org/2001/XMLSchema#string

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P50

Gillian M Keating

P577

2016-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1007103748

http://www.w3.org/2001/XMLSchema#string

P698

27550544

http://www.w3.org/2001/XMLSchema#string